Vanguard Personalized Indexing Management, LLC Novavax Inc Transaction History

Vanguard Personalized Indexing Management, LLC

  • $6.09 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$36.28 - $75.29 $163,187 - $338,654
-4,498 Reduced 50.86%
4,346 $224,000
Q1 2022

May 16, 2022
BUY
$69.73 - $142.9 $280,942 - $575,744
4,029 Added 83.68%
8,844 $651,000
Q4 2021

Feb 23, 2022
BUY
$134.56 - $217.97 $181,386 - $293,823
1,348 Added 38.88%
4,815 $689,000
Q3 2021

Nov 09, 2021
BUY
$177.8 - $270.58 $208,026 - $316,578
1,170 Added 50.94%
3,467 $719,000
Q2 2021

Aug 11, 2021
BUY
$121.0 - $257.67 $277,937 - $591,867
2,297 New
2,297 $488,000

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email